| Prostate Cancer |
1 |
1 |
| Breast Cancer |
0 |
0.93 |
| Lung Cancer |
0 |
0.88 |
| Cancer |
0 |
0.86 |
| Small Cell Lung Cancer |
0 |
0.8 |
| Non-Small Cell Lung Cancer |
0 |
0.69 |
| Cancer Survivor |
0 |
0.63 |
| Biologic Therapy |
0 |
0.62 |
| Metastasis |
0 |
0.62 |
| Ovarian Cancer |
0 |
0.62 |
| Targeted Cancer Therapy |
0 |
0.62 |
| Toxicology |
0 |
0.51 |
| Lung |
0 |
0.36 |
| Prostate |
0 |
0.28 |
| Lung Resection |
0 |
0.23 |
| Pulmonary Nodule |
0 |
0.09 |
| Biomarker |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Nodule |
0 |
0.07 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Cataract |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Muscular Atrophy |
0 |
0.06 |
| Oklahoma |
0 |
0.06 |
| Radiation Therapy |
0 |
0.06 |
| Sarcopenia |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Tumor |
0 |
0.06 |